MASLD Weight Loss — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Weight loss ≥10% of body weight
Weight loss ≥10% is associated with fibrosis regression in NASH. GLP-1 RAs facilitate this. Resmetirom is emerging as a specific MASH therapy.
Reference: eTG – 2025 – Gastrointestinal; AASLD – 2023